Flagship explainer
What drives Lucid Diagnostics Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$58M | FY2025 |
| |
| Income before tax | −$58M | FY2025 |
|
| Operating income | −$49.6M | FY2025 |
|
| $4.7M | FY2025 |
| |
| Ending assets | $40.4M | FY2025 |
|
| Beginning assets | $30.7M | FY2024 |
|
| $10.9M | FY2025 |
| |
| $5.4M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001437749-26-009805
- SEC filingFiling detailsAccession 0001641172-25-000205